<?xml version='1.0' encoding='UTF-8'?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:webfeeds="http://webfeeds.org/rss/1.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title>eLife: latest articles by subject</title>
    <link>https://elifesciences.org</link>
    <description>Articles published by eLife, filtered by given subjects</description>
    <atom:link href="https://observer.elifesciences.org/report/latest-articles-by-subject" rel="self"/>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>observer (using python-feedgen)</generator>
    <language>en</language>
    <lastBuildDate>Fri, 09 Oct 2026 14:31:44 +0000</lastBuildDate>
    <webfeeds:analytics id="G-TZ0BM7CV5E" engine="GoogleAnalytics"/>
    <item>
      <title>Distinct allosteric remodeling of HIV-1 Env dynamics on virions by gp41-directed antibodies reveals two modes of neutralization</title>
      <link>https://elifesciences.org/articles/110887</link>
      <description>HIV-1 envelope glycoprotein (Env), a gp120–gp41 trimer, undergoes coordinated conformational changes that drive membrane fusion and allow immune evasion by transiently concealing neutralization-sensitive epitopes. Most broadly neutralizing antibodies (bNAbs) target gp120, whereas a distinct subset recognizes conserved gp41 regions, such as the fusion peptide and the membrane-proximal external region; however, their impact on Env dynamics and associated neutralization mechanisms remains unclear. By using bioorthogonal tagging for single-molecule FRET, we monitored real-time bNAb-induced conformational sampling of Env on intact virions. Most gp41-directed bNAbs allosterically stabilized the prefusion-closed (PC) state, whereas the bivalent 10E8.4/iMab favored both PC and CD4-bound open (predominant) states. Antibodies redistributed the conformational populations of Env with modest kinetic effects, preserving a sequential transition pathway. These findings reveal two modes of neutralization for gp41-directed antibodies, fixing the PC conformation and opening it up – in both cases, with neutralization occurring via long-range allosteric control of Env dynamics.</description>
      <author>maolin.lu@uthct.edu (Baoshan Zhang)</author>
      <author>maolin.lu@uthct.edu (Bo Hu)</author>
      <author>maolin.lu@uthct.edu (David D Ho)</author>
      <author>maolin.lu@uthct.edu (Harry Baffour Awuah)</author>
      <author>maolin.lu@uthct.edu (Jian Yu)</author>
      <author>maolin.lu@uthct.edu (Junyu Liu)</author>
      <author>maolin.lu@uthct.edu (Maolin Lu)</author>
      <author>maolin.lu@uthct.edu (Narendra Kumar Gonepudi)</author>
      <author>maolin.lu@uthct.edu (Peter D Kwong)</author>
      <author>maolin.lu@uthct.edu (Priyamvada Acharya)</author>
      <author>maolin.lu@uthct.edu (Ran Wang)</author>
      <author>maolin.lu@uthct.edu (Revansiddha Katte)</author>
      <author>maolin.lu@uthct.edu (Wang Xu)</author>
      <author>maolin.lu@uthct.edu (Yang Han)</author>
      <author>maolin.lu@uthct.edu (Yufan He)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.110887</guid>
      <category>Microbiology and Infectious Disease</category>
      <category>Structural Biology and Molecular Biophysics</category>
      <pubDate>Fri, 02 Oct 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-10-02T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Gβγ engages PLCβ3 at multiple sites to reorient and facilitate its activation</title>
      <link>https://elifesciences.org/articles/110382</link>
      <description>Phospholipase C β (PLCβ) enzymes are activated by heterotrimeric G protein subunits, increasing hydrolysis of phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2) at the plasma membrane. All four human PLCβ isoforms (PLCβ1–4) are activated by Gα&lt;sub&gt;q&lt;/sub&gt;, whereas PLCβ1–3 are activated to varying extents by Gβγ. The binding sites for Gα&lt;sub&gt;q&lt;/sub&gt; on PLCβ are well established, and much has been learned about its mechanism of activation, but comparatively little is known about Gβγ-dependent activation. In this work, we used cryo-electron microscopy single-particle analysis, functional assays, and bioluminescence resonance energy transfer to investigate how Gβγ interacts with PLCβ3 in concert with activated Gα&lt;sub&gt;q&lt;/sub&gt; to regulate phospholipase activity. Gβγ heterodimers bind multiple surfaces of PLCβ3 to promote activation, but alone do not recruit the enzyme to the plasma membrane. Instead, Gβγ facilitates activation by Gα&lt;sub&gt;q&lt;/sub&gt;, most likely by reorienting the phospholipase catalytic site at the membrane to maximize PI(4,5)P2 hydrolysis and downstream Ca&lt;sup&gt;2+&lt;/sup&gt; release. Cell-based functional assays demonstrate that Gβγ is required for maximal PLCβ3 activation, even when G&lt;sub&gt;q&lt;/sub&gt; heterotrimers are the sole source of Gβγ. Together, these findings demonstrate that Gβγ acts as a critical positive allosteric modulator that regularly acts in concert with Gα&lt;sub&gt;q&lt;/sub&gt; to activate PLCβ3 at the plasma membrane.</description>
      <author>lyonam@purdue.edu (Angeline M Lyon)</author>
      <author>lyonam@purdue.edu (Asuka Inoue)</author>
      <author>lyonam@purdue.edu (Elisabeth E Garland-Kuntz)</author>
      <author>lyonam@purdue.edu (Evi Kostenis)</author>
      <author>lyonam@purdue.edu (Isaac J Fisher)</author>
      <author>lyonam@purdue.edu (Kanishka Senarath)</author>
      <author>lyonam@purdue.edu (Kaushik Muralidharan)</author>
      <author>lyonam@purdue.edu (Kennedy Outlaw)</author>
      <author>lyonam@purdue.edu (Leon F Laskowski)</author>
      <author>lyonam@purdue.edu (Michelle M Van Camp)</author>
      <author>lyonam@purdue.edu (Nevin A Lambert)</author>
      <author>lyonam@purdue.edu (Thomas Komay)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.110382</guid>
      <category>Biochemistry and Chemical Biology</category>
      <category>Structural Biology and Molecular Biophysics</category>
      <pubDate>Wed, 30 Sep 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-09-30T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Bifunctional architecture enables substrate catalysis and channeling in &lt;i&gt;Paracoccus&lt;/i&gt; TMAO demethylase</title>
      <link>https://elifesciences.org/articles/109964</link>
      <description>Substrate channeling enhances efficiency and prevents toxicity by directing unstable intermediates between active sites. Trimethylamine N-oxide demethylase (TDM) degrades trimethylamine N-oxide (TMAO) to dimethylamine and formaldehyde (HCHO), but the fate of HCHO has remained unclear. We report cryo-EM structures of TDM in apo, substrate-, and product-bound states that reveal a previously unknown channeling pathway. Combined structural, biochemical, and target molecular dynamics analyses show that HCHO is generated in a catalytic core and guided through a tunnel to a remote tetrahydrofolate (THF)-binding site, where it forms methylene-THF. Thus, TDM emerges as a bifunctional enzyme that unites TMAO demethylation with one-carbon transfer, providing a mechanistic explanation for its role in metabolic efficiency and detoxification.</description>
      <author>ttthach@purdue.edu (Gurunath Ramanathan)</author>
      <author>ttthach@purdue.edu (Jane Allison)</author>
      <author>ttthach@purdue.edu (KanagaVijayan Dhanabalan)</author>
      <author>ttthach@purdue.edu (Ramaswamy Subramanian)</author>
      <author>ttthach@purdue.edu (Senwei Quan)</author>
      <author>ttthach@purdue.edu (Shiwangi Maurya)</author>
      <author>ttthach@purdue.edu (Trung Thach)</author>
      <author>ttthach@purdue.edu (Yu Han-Hallett)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.109964</guid>
      <category>Structural Biology and Molecular Biophysics</category>
      <pubDate>Mon, 28 Sep 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-09-28T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Two Glu/Asp residues cooperatively mediate an early step of ATP hydrolysis in GHKL ATPases MutL and GyrB</title>
      <link>https://elifesciences.org/articles/111443</link>
      <description>GHKL ATPases share a unique Bergerat ATP-binding fold and regulate diverse biological processes through ATP-dependent conformational changes. An early step of ATP hydrolysis in this family has been attributed to a single highly conserved glutamate residue proposed to function as the general base. However, mutations of this residue impair both the ATPase activity and ATP binding, complicating interpretation of its catalytic role. Re-examination of the high-resolution crystal structures revealed a second conserved acidic residue positioned within a hydrogen-bonding distance from the nucleophilic water molecule. Using &lt;i&gt;Aquifex aeolicus&lt;/i&gt; MutL and GyrB as model enzymes, we combined systematic mutagenesis, ATPase and ATP-binding assays, and X-ray crystallography to dissect the roles of these residues. We show that alignment of the nucleophilic water can be maintained as long as the conserved glutamate retains hydrogen-bonding capability, whereas efficient ATP hydrolysis requires proton-accepting capacity at least in one of the two acidic residues. These results indicate that the conserved glutamate primarily governs positioning of the nucleophilic water, while activation of this water for catalysis is achieved through cooperative general base function of the two acidic residues. Extending this framework to human MutL homologs, PMS2 and MLH1, we showed that clinically reported variants of uncertain significance in these DNA mismatch repair proteins substantially reduced the ATPase activity, indicating functional impairment. Together, our findings refine the catalytic mechanism of GHKL ATPases and provide a structural and functional framework for interpreting disease-associated variants in GHKL ATPases. Phylogenetic and ancestral state analysis further indicated that the second acidic residue was likely to be present in the common ancestor of major GHKL ATPase lineages but was later modified in a branch, including Hsp90, suggesting evolutionary remodeling of the catalytic mechanism in the branch.</description>
      <author>kenji.fukui@cc.nara-wu.ac.jp (Ayaka Shibuya)</author>
      <author>kenji.fukui@cc.nara-wu.ac.jp (Kenji Fukui)</author>
      <author>kenji.fukui@cc.nara-wu.ac.jp (Takato Yano)</author>
      <author>kenji.fukui@cc.nara-wu.ac.jp (Takeshi Murakawa)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.111443</guid>
      <category>Structural Biology and Molecular Biophysics</category>
      <pubDate>Fri, 25 Sep 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-09-25T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>A biochemical mechanism for Stu2/XMAP215-family microtubule polymerases</title>
      <link>https://elifesciences.org/articles/107818</link>
      <description>Defining quantitative biochemical mechanisms of microtubule dynamics and regulation is a current challenge. Stu2/XMAP215-family polymerases use tubulin-binding TOG domains to catalyze microtubule growth, but how polymerase activity results from the number and tubulin-binding properties of TOGs is not understood. We tested whether an enzyme-like biochemical model for the unrelated actin polymerase Ena/VASP could be applied to quantitatively relate Stu2 microtubule polymerase activity to the number of its TOGs, and the rate constants governing their interactions with tubulin. Stu2 activity displayed enzyme-like characteristics consistent with the biochemical model: Stu2 stimulated microtubule growth rates with hyperbolic dependence on tubulin concentration, and the amount of Stu2 on the microtubule end did not vary with tubulin concentration (microtubule growth rate). Complementary measurements of TOG:tubulin binding revealed high affinity (10 nM) and slow dissociation (0.03 s&lt;sup&gt;–1&lt;/sup&gt;). The polymerase and binding measurements can be unified within the biochemical model: Stu2 operates with high efficiency, acting as a tubulin-shuttling antenna on the microtubule end that is primarily limited by the rate of tubulin:TOG association. Our work thus provides a quantitative biochemical mechanism for TOG-based polymerases. That unrelated microtubule and actin polymerases use the same enzyme-like mechanism provides an example of convergent evolution in the cytoskeleton.</description>
      <author>Luke.Rice@UTSouthwestern.edu (Binnu Gangadharan)</author>
      <author>Luke.Rice@UTSouthwestern.edu (Daniel L Kober)</author>
      <author>Luke.Rice@UTSouthwestern.edu (Luke M Rice)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.107818</guid>
      <category>Cell Biology</category>
      <category>Structural Biology and Molecular Biophysics</category>
      <pubDate>Thu, 03 Sep 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-09-03T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>&lt;i&gt;In extracto&lt;/i&gt; cryo-EM reveals eEF2 as a major hibernation factor on 60S and 80S particles</title>
      <link>https://elifesciences.org/articles/110114</link>
      <description>Cryogenic electron microscopy (cryo-EM) made impressive progress in resolving cellular macromolecules and their detailed interactions. Single-particle cryo-EM traditionally relies on purified macromolecules and lacks the complexity of cellular environments, whereas &lt;i&gt;in situ&lt;/i&gt; cryo-EM and cryogenic electron tomography (cryo-ET) require extensive sample preparation and data acquisition, presenting challenges in achieving high resolution. We describe cryo-EM of cellular lysates—&lt;i&gt;in extracto&lt;/i&gt; cryo-EM—allowing the flexibility and high-resolution of cryo-EM in the context of cellular components. High-resolution 2D template matching (2DTM) yields ~2.2 Å maps of the mammalian translational apparatus. Elongating ribosome abundances in primate cell lines (MCF-7 and BSC-1) and rabbit reticulocyte lysates range from ~70% to ~10%, reflecting translational stress responses. Non-translating (hibernating) ribosomes carrying no mRNA feature numerous proteins shielding ribosomal functional centers. Elongation factor 2 (eEF2) is the most abundant hibernation factor bound to &amp;gt;95% of 80S ribosomes and, unexpectedly, to 60S subunits. eEF2•GDP is stabilized by interactions with the sarcin-ricin loop and protein uL14. Hibernating ribosomes also feature La-related protein 1 (LARP1) involved in initiation and mTOR signaling, eIF5A implicated in elongation and termination, and other factors, exposing the variety of hibernation scenarios. Our work underscores the efficiency and potential of &lt;i&gt;in extracto&lt;/i&gt; cryo-EM to discover native cellular complexes and mechanisms at near-atomic resolution.</description>
      <author>niko@grigorieff.org (Andrei A Korostelev)</author>
      <author>niko@grigorieff.org (Anna B Loveland)</author>
      <author>niko@grigorieff.org (ChunYing Huang)</author>
      <author>niko@grigorieff.org (Emily Sholi)</author>
      <author>niko@grigorieff.org (Nikolaus Grigorieff)</author>
      <author>niko@grigorieff.org (Stephen Diggs)</author>
      <author>niko@grigorieff.org (Ximena Zottig)</author>
      <author>niko@grigorieff.org (Zahra Seraj)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.110114</guid>
      <category>Structural Biology and Molecular Biophysics</category>
      <pubDate>Thu, 03 Sep 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-09-03T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>A membrane insertion code for intrinsically disordered proteins</title>
      <link>https://elifesciences.org/articles/111515</link>
      <description>Membrane association of intrinsically disordered proteins (IDPs) mediates various cellular functions including membrane remodeling and signal transduction. Whereas membrane association through amphipathic helices and polybasic motifs is well understood, sequence determinants for the insertion of aromatic residues into the membrane hydrophobic core are still poorly characterized. Here, we decipher the sequence code for membrane insertion of aromatic-centered motifs. For an initial set of ten 9-residue aromatic-centered sequences, all-atom molecular dynamics simulations and the positioning of proteins in membranes (PPM) method produced very similar membrane insertion propensities. Applying PPM to a full library of 1.2×10&lt;sup&gt;6&lt;/sup&gt; sequences with an F, W, or Y residue flanked by L, R, G, N, or E at four positions on either side, we found that aliphatic (L) and basic (R) residues favor membrane insertion, whereas acidic (E) and polar (N) residues disfavor it. Guided by these rules, we developed a mathematical model dubbed AroMIP (Aromatic Membrane Insertion Predictor) to predict the membrane insertion propensities of aromatic-centered motifs. AroMIP achieves 91.2, 92.0, and 99.7% accuracies for F-, W-, and Y-centered motifs, respectively, in disordered regions of the human proteome and is available as a web server at &lt;a href="https://zhougroup-uic.github.io/AroMIP/"&gt;https://zhougroup-uic.github.io/AroMIP/&lt;/a&gt;. The present work provides the sequence basis and a mechanistic understanding of how IDPs employ aromatic-centered motifs to drive membrane insertion, and enriches the tools for the study of IDP-membrane association.</description>
      <author>hzhou43@uic.edu (Fidha Nazreen Kunnath Muhammedkutty)</author>
      <author>hzhou43@uic.edu (Huan-Xiang Zhou)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.111515</guid>
      <category>Structural Biology and Molecular Biophysics</category>
      <pubDate>Wed, 26 Aug 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-08-26T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Characterization of an early-diverging KCNE potassium-channel auxiliary subunit in the jawless vertebrate lamprey</title>
      <link>https://elifesciences.org/articles/111781</link>
      <description>The KCNE (KCNE1–6) proteins are single-pass transmembrane auxiliary subunits of the voltage-gated K&lt;sup&gt;+&lt;/sup&gt; channel KCNQ1. KCNQ1–KCNE complexes have been well studied in jawed vertebrates ranging from zebrafish to humans, but KCNE subunits from earlier-diverging vertebrates remain poorly characterized. Here, we functionally characterize a single KCNE-like gene in lamprey, a jawless vertebrate, and designate it &lt;i&gt;kcne0&lt;/i&gt; as an early-diverging member of the KCNE family. KCNE0 shows moderate amino acid sequence similarity to KCNE1–6 but is not particularly similar to any single isoform. Both &lt;i&gt;kcnq1&lt;/i&gt; and &lt;i&gt;kcne0&lt;/i&gt; transcripts were detected in multiple lamprey organs. When co-expressed with lamprey KCNQ1, KCNE0 produced a constitutively active current, similar to KCNE3. By contrast, KCNE0 modulated KCNQ1 from other species less effectively, suggesting species-specific tuning of KCNQ1–KCNE compatibility. Introducing into KCNE0 an intracellular tetra-leucine motif analogous to that in KCNE4 markedly reduced KCNQ1 current amplitude, conferring a KCNE4-like inhibitory effect. Overall, this work provides a functional reference for comparing KCNE-dependent modulation of KCNQ1 across vertebrates and suggests an underlying compatibility mechanism.</description>
      <author>gokasuya@jichi.ac.jp (Buntaro Zempo)</author>
      <author>gokasuya@jichi.ac.jp (Emi Kawano-Yamashita)</author>
      <author>gokasuya@jichi.ac.jp (Go Kasuya)</author>
      <author>gokasuya@jichi.ac.jp (Kaei Ryu)</author>
      <author>gokasuya@jichi.ac.jp (Koichi Nakajo)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.111781</guid>
      <category>Structural Biology and Molecular Biophysics</category>
      <pubDate>Wed, 26 Aug 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-08-26T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Optimising the tilt increment for in situ cryo-electron tomography</title>
      <link>https://elifesciences.org/articles/111639</link>
      <description>Cryo-electron tomography (cryo-ET) enables high-resolution, three-dimensional imaging of cellular structures in their native, frozen state. However, image quality is limited by a trade-off between angular sampling and radiation damage. Therefore, the choice of the angular increment during data collection is a critical parameter that affects tomogram quality and downstream analyses. Optimising this increment is challenging due to the high demands on microscope time, storage, and computation. In this study, we systematically evaluated tilt increments of 1°, 2°, 3°, 5°, and 10° using lamellae from &lt;i&gt;Dictyostelium discoideum&lt;/i&gt; cells. We found that at a constant total electron dose, finer tilt increments (1–3°) produced better-aligned tomograms with higher signal-to-noise ratios and improved outcomes in template matching and subtomogram averaging. A 3° increment emerged as the optimal balance between data quality, alignment accuracy, dose per image, and processing efficiency. This practical recommendation supports both high-throughput and high-resolution structural studies and can guide future cryo-ET data acquisition strategies.</description>
      <author>Martin.Beck@biophys.mpg.de (Beata Turoňová)</author>
      <author>Martin.Beck@biophys.mpg.de (Maarten Willem Tuijtel)</author>
      <author>Martin.Beck@biophys.mpg.de (Martin Beck)</author>
      <author>Martin.Beck@biophys.mpg.de (Tomáš Majtner)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.111639</guid>
      <category>Structural Biology and Molecular Biophysics</category>
      <pubDate>Mon, 24 Aug 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-08-24T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Probing relaxed myosin states in hypertrophic cardiomyopathy by second harmonic-generation microscopy</title>
      <link>https://elifesciences.org/articles/107730</link>
      <description>This study explores the use of polarized second-harmonic generation (pSHG) to investigate myosin conformation in the relaxed state, differentiating between the actin-available, disordered (ON) state and the energy-conserving, ordered (OFF) state. By shifting the ON/OFF equilibrium using both physical and chemical manipulations, we demonstrate the sensitivity of pSHG in quantifying the ON/OFF ratio in skeletal and cardiac tissues. Comparisons with X-ray diffraction measurements further validate our findings. Applying this approach to a sarcomeric mutation associated with hypertrophic cardiomyopathy, we show that R403Q/MYH7-mutated minipig ventricle tissue exhibits a higher ON fraction compared to controls. This difference is abolished under high concentrations of a myosin activator (2-deoxyATP) and an inhibitor (Mavacamten), indicating structural similarity between R403Q and controls in these two states. ATPase assays reveal increased resting ATPase activity in R403Q samples, which persists even in the presence of 2-deoxyATP, suggesting that the elevated energy consumption in the R403Q mutation is driven by both a population shift toward the ON state and enhanced myosin ATPase activity per motor head.</description>
      <author>leonardo.sacconi@cnr.it (Beatrice Scellini)</author>
      <author>leonardo.sacconi@cnr.it (Caroline Muellenbroich)</author>
      <author>leonardo.sacconi@cnr.it (Cecilia Ferrantini)</author>
      <author>leonardo.sacconi@cnr.it (Chiara Tesi)</author>
      <author>leonardo.sacconi@cnr.it (Corrado Poggesi)</author>
      <author>leonardo.sacconi@cnr.it (Francesco Sera)</author>
      <author>leonardo.sacconi@cnr.it (Giulia Arecchi)</author>
      <author>leonardo.sacconi@cnr.it (Jingyuan Yu)</author>
      <author>leonardo.sacconi@cnr.it (Jing Zhao)</author>
      <author>leonardo.sacconi@cnr.it (Leonardo Sacconi)</author>
      <author>leonardo.sacconi@cnr.it (Marica Dente)</author>
      <author>leonardo.sacconi@cnr.it (Marina Scardigli)</author>
      <author>leonardo.sacconi@cnr.it (Michael Regnier)</author>
      <author>leonardo.sacconi@cnr.it (Nicoletta Piroddi)</author>
      <author>leonardo.sacconi@cnr.it (Riccardo Cicchi)</author>
      <author>leonardo.sacconi@cnr.it (Ryo Kinegawa)</author>
      <author>leonardo.sacconi@cnr.it (Thomas C Irving)</author>
      <author>leonardo.sacconi@cnr.it (Weikang Ma)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.107730</guid>
      <category>Physiology</category>
      <category>Structural Biology and Molecular Biophysics</category>
      <pubDate>Mon, 17 Aug 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-08-17T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Cryo-EM structure of the bicarbonate receptor GPR30</title>
      <link>https://elifesciences.org/articles/99874</link>
      <description>G-protein-coupled receptor 30 (GPR30) is a bicarbonate receptor that plays a vital role in cellular responses to extracellular pH and ion homeostasis. Despite its significance, the mechanisms by which GPR30 interacts with bicarbonate ions remain elusive. There is no consensus on a drug that targets GPR30, and difficulties in pharmacological analyses have limited biological and drug discovery research on GPR30. Here, we present the cryo-electron microscopy structure of human GPR30 in the presence of bicarbonate ions at 3.15 Å resolution. Our structure reveals unique extracellular pockets and critical residues for bicarbonate binding and activation. Functional assays demonstrate that mutations in these residues impair bicarbonate-induced GPR30 activation, underscoring their importance in receptor function. This study also provides insights into G-protein coupling, highlighting the structural divergence between GPR30 and other G-protein-coupled receptors (GPCRs). Our findings not only advance the understanding of the role of GPR30 in pH homeostasis but also pave the way for the development of high-affinity drugs targeting GPR30 for therapeutic interventions in diseases associated with acid-base imbalance.</description>
      <author>awatanabe-tky@umin.ac.jp (Airi Jo-Watanabe)</author>
      <author>awatanabe-tky@umin.ac.jp (Hidetaka S Oshima)</author>
      <author>awatanabe-tky@umin.ac.jp (Hiroaki Akasaka)</author>
      <author>awatanabe-tky@umin.ac.jp (Osamu Nureki)</author>
      <author>awatanabe-tky@umin.ac.jp (Shota Kaneda)</author>
      <author>awatanabe-tky@umin.ac.jp (Takehiko Yokomizo)</author>
      <author>awatanabe-tky@umin.ac.jp (Wataru Shihoya)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.99874</guid>
      <category>Structural Biology and Molecular Biophysics</category>
      <pubDate>Fri, 14 Aug 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-08-14T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>ATP-driven conformational dynamics reveal hidden intermediates in a heterodimeric ABC transporter</title>
      <link>https://elifesciences.org/articles/110967</link>
      <description>ATP-binding cassette (ABC) transporters are essential molecular machines whose conformational dynamics have largely been inferred from ensemble-averaged measurements. Resolving dynamic heterogeneity and transient intermediates, however, requires single-molecule approaches. Here, we use single-molecule Förster resonance energy transfer (smFRET) to resolve ATP-driven conformational dynamics of the heterodimeric type IV ABC transporter TmrAB, a functional homolog of the human antigen transporter TAP, at the level of individual molecules. Fluorophores positioned at the nucleotide-binding domains and periplasmic gate were validated by accessible-volume simulations, fluorescence lifetimes, and ensemble FRET, demonstrating that these reporters reliably track conformational transitions. Single-molecule analysis distinguishes ATP-free and ATP-bound states and quantifies ATP-dependent population shifts from nucleotide-free to physiological ATP concentrations. Kinetic analysis further reveals an unexpectedly long ATP-bound dwell time of ~300 ms. Using complementary stabilization strategies, we directly resolve a previously hidden outward-facing open state that is kinetically masked under turnover conditions. These results provide the first single-molecule characterization of TmrAB and establish a quantitative single-molecule framework for dissecting ATP-coupled conformational dynamics in heterodimeric ABC transporters.</description>
      <author>tampe@em.uni-frankfurt.de (Christoph Nocker)</author>
      <author>tampe@em.uni-frankfurt.de (Matija Pečak)</author>
      <author>tampe@em.uni-frankfurt.de (Robert Tampé)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.110967</guid>
      <category>Biochemistry and Chemical Biology</category>
      <category>Structural Biology and Molecular Biophysics</category>
      <pubDate>Fri, 31 Jul 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-07-31T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>In-cell cryo-electron tomography reveals differential effects of type I and type II kinase inhibitors on LRRK2 filament formation and microtubule association</title>
      <link>https://elifesciences.org/articles/111075</link>
      <description>Mutations in leucine-rich repeat kinase 2 (LRRK2) are a leading contributor to developing familial and idiopathic Parkinson’s disease (PD). Most PD-causing LRRK2 mutations increase the kinase activity, leading to increased phosphorylation of Rab GTPases, disrupting vesicular trafficking, cytoskeletal dynamics, and autophagy. Under homeostatic conditions, the bulk of WT and PD-mutant LRRK2 is found in the cellular cytosol. However, exogenously expressed LRRK2 can form microtubule-associated filaments that have been shown to affect molecular transport along microtubules in vitro. While the physiological relevance of microtubule binding has not been established yet, inhibitors being designed and tested as therapeutics have been shown to either promote or prevent filament formation of LRRK2. In this study, we examine the localization and resulting molecular organization of hyperactive LRRK2-I2020T, a common PD mutant, in HEK 293FT cells treated with type I (MLi-2) or type II (GZD-824) kinase inhibitors. Treatment with a type I kinase inhibitor results in extensive LRRK2-I2020T decoration around microtubules and microtubule bundling. Stabilization of LRRK2-I2020T filaments by type I inhibitor treatment allowed us to build a full-length closed-kinase model of LRRK2-I2020T in its cellular environment. Conversely, treatment with a type II inhibitor resulted in minimal microtubule decoration by LRRK2-I2020T compared to type I inhibitor-treated cells. This study provides a structural framework for understanding how type I and type II kinase inhibitors differentially modulate LRRK2 filament formation, demonstrating that type I inhibitor treatment promotes a distinct filament architecture, whereas such assemblies are not observed with type II inhibitors.</description>
      <author>aleschziner@ucsd.edu (Andres E Leschziner)</author>
      <author>aleschziner@ucsd.edu (Elizabeth Villa)</author>
      <author>aleschziner@ucsd.edu (Eva P Karasmanis)</author>
      <author>aleschziner@ucsd.edu (Joshua Hutchings)</author>
      <author>aleschziner@ucsd.edu (Siyu Chen)</author>
      <author>aleschziner@ucsd.edu (Tamar Basiashvili)</author>
      <author>aleschziner@ucsd.edu (William Alexander Flaherty)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.111075</guid>
      <category>Structural Biology and Molecular Biophysics</category>
      <pubDate>Mon, 27 Jul 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-07-27T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Structural dynamics of IRE1 and its interaction with unfolded peptides</title>
      <link>https://elifesciences.org/articles/106716</link>
      <description>The unfolded protein response (UPR) is a crucial signaling network that preserves endoplasmic reticulum (ER) homeostasis, impacting both health and disease. When ER stress occurs, often due to an accumulation of unfolded proteins in the ER lumen, the UPR initiates a broad cellular program to counteract cytotoxic effects. Inositol-requiring enzyme 1 (IRE1), a conserved ER-bound protein, is a key sensor of ER stress and activator of the UPR. While biochemical studies confirm IRE1’s role in recognizing unfolded polypeptides, high-resolution structures showing direct interactions remain elusive. Consequently, the precise structural mechanism by which IRE1 senses unfolded proteins is debated. In this study, we employed advanced molecular modeling and 137 µs of atomistic molecular dynamics simulations to clarify how IRE1 detects unfolded proteins. Our results demonstrate that IRE1’s luminal domain directly interacts with unfolded peptides and reveal how these interactions can stabilize higher-order oligomers. We provide a detailed molecular characterization of unfolded peptide binding, identifying two distinct binding pockets at the dimer’s center, separate from its central groove. Furthermore, we present high-resolution structures illustrating how BiP associates with IRE1’s oligomerization interface, thus preventing the formation of larger complexes. Our structural model reconciles seemingly contradictory experimental findings, offering a unified perspective on the diverse sensing models proposed. We elucidate the structural dynamics of unfolded protein sensing by IRE1, providing key insights into the initial activation of the UPR.</description>
      <author>covino@fias.uni-frankfurt.de (Elena Spinetti)</author>
      <author>covino@fias.uni-frankfurt.de (Grzegorz Ścibisz)</author>
      <author>covino@fias.uni-frankfurt.de (Gülsün Elif Karagöz)</author>
      <author>covino@fias.uni-frankfurt.de (Roberto Covino)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.106716</guid>
      <category>Structural Biology and Molecular Biophysics</category>
      <pubDate>Thu, 23 Jul 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-07-23T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>RNA selectively modulates activity of virulent amyloid PSMα3 and host-defense LL-37 via phase separation and aggregation dynamics</title>
      <link>https://elifesciences.org/articles/109290</link>
      <description>Amyloid-forming peptides are increasingly recognized as dynamic regulators at the host–pathogen interface, yet how environmental factors control their assembly and activity remains poorly understood. Here, RNA acts as a concentration-dependent regulator of two sequence-related α-helical peptides with fundamentally different assembly behaviors: the cross-α amyloid-forming &lt;i&gt;Staphylococcus aureus&lt;/i&gt; virulence factor PSMα3 and the non-amyloidogenic human host-defense peptide LL-37. RNA drives PSMα3 through distinct assembly states, from liquid-like condensates to fibrillar polymorphs, while preserving cytotoxic and antimicrobial activity over time. In contrast, RNA attenuates LL-37 cytotoxicity toward host cells while maintaining antibacterial activity, consistent with a host-protective immunomodulatory effect. Together with the opposing effects of epigallocatechin gallate, which redirects both peptides into amorphous assemblies, these findings support a mechanistic model in which biological activity is governed by supramolecular architecture, assembly trajectory, and dynamics rather than by monomer abundance or mature fibrils alone. More broadly, our findings identify RNA as an environmental regulator of α-helical peptide assemblies, and establish assembly-state control as a tunable determinant of virulence and host defense.</description>
      <author>meytal.landau@desy.de (Alexander Kai Buell)</author>
      <author>meytal.landau@desy.de (Alexander Upcher)</author>
      <author>meytal.landau@desy.de (Amir Argoetti)</author>
      <author>meytal.landau@desy.de (Bader Rayan)</author>
      <author>meytal.landau@desy.de (Christian F Pantoja)</author>
      <author>meytal.landau@desy.de (Eilon Barnea)</author>
      <author>meytal.landau@desy.de (Jacob Aunstrup Larsen)</author>
      <author>meytal.landau@desy.de (Jesse Gayk)</author>
      <author>meytal.landau@desy.de (Markus Zweckstetter)</author>
      <author>meytal.landau@desy.de (Meytal Landau)</author>
      <author>meytal.landau@desy.de (Rinat Indig)</author>
      <author>meytal.landau@desy.de (Yael Lupu-Haber)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.109290</guid>
      <category>Microbiology and Infectious Disease</category>
      <category>Structural Biology and Molecular Biophysics</category>
      <pubDate>Mon, 20 Jul 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-07-20T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Enhanced processivity and collective force production of kinesin-1 at low radial forces</title>
      <link>https://elifesciences.org/articles/109012</link>
      <description>Kinesin-1 is a robust motor that carries intracellular cargos toward the plus ends of microtubules. However, optical trapping studies reported that kinesin-1 is a slippery motor that quickly detaches from the microtubule, and multiple kinesins are incapable of teaming up to generate large collective forces. This may be due to the vertical (z) forces that the motor experiences in a single bead trapping assay, accelerating the detachment of the motor from a microtubule. Here, we substantially lowered the z-force by using a long DNA handle between the motor and the trapped bead and characterized the motility and force generation of single and multiple human kinesin-1 motors in vitro. Contrary to previous views, we show that kinesin-1 is a robust motor that resists microtubule detachment before it reaches high hindering forces, but it quickly detaches under assisting forces even at low z-forces. We also demonstrate highly efficient collective force generation by multiple kinesin-1 motors. These results provide an explanation for how multiple kinesins team up to perform cellular functions that require higher forces than a single motor can bear.</description>
      <author>yildiz@berkeley.edu (Ahmet Yildiz)</author>
      <author>yildiz@berkeley.edu (Andrew M Hensley)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.109012</guid>
      <category>Structural Biology and Molecular Biophysics</category>
      <pubDate>Mon, 20 Jul 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-07-20T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>In silico design and validation of high-affinity RNA aptamers for SARS-CoV-2 comparable to neutralizing antibodies</title>
      <link>https://elifesciences.org/articles/107785</link>
      <description>Nucleic acid aptamers hold promise for clinical applications, yet understanding their molecular binding mechanisms to target proteins, and efficiently optimizing their binding affinities, remain challenging. Here, we present CAAMO (&lt;i&gt;C&lt;/i&gt;omputer-&lt;i&gt;A&lt;/i&gt;ided &lt;i&gt;A&lt;/i&gt;ptamer &lt;i&gt;M&lt;/i&gt;odeling and &lt;i&gt;O&lt;/i&gt;ptimization), which integrates in silico aptamer design with experimental validation to accelerate the development of aptamer-based RNA therapeutics. Starting from the sequence information of a reported RNA aptamer, Ta, for the SARS-CoV-2 spike protein, our CAAMO method first determines its binding mode with the spike protein’s receptor binding domain (RBD) through a multi-strategy computational approach. We then optimize its binding affinity via structure-based rational design. Among the six designed candidates, five were experimentally verified and exhibited enhanced binding affinities compared to the original Ta sequence. Furthermore, we directly compared the binding properties of the RNA aptamers to neutralizing antibodies and found that the designed aptamer Ta&lt;sup&gt;G34C&lt;/sup&gt; demonstrated a comparable binding affinity to the RBD compared to the representative neutralizing antibodies analyzed in this study. This highlights its potential as an alternative to existing COVID-19 antibodies. Our work provides a robust approach for the efficient design of a relatively large number of high-affinity aptamers with complicated topologies. This approach paves the way for the development of aptamer-based RNA diagnostics and therapeutics.</description>
      <author>wangzhiye1@zju.edu.cn (Damiano Buratto)</author>
      <author>wangzhiye1@zju.edu.cn (Dong Zhang)</author>
      <author>wangzhiye1@zju.edu.cn (Liquan Huang)</author>
      <author>wangzhiye1@zju.edu.cn (Lulu Qiao)</author>
      <author>wangzhiye1@zju.edu.cn (Ruhong Zhou)</author>
      <author>wangzhiye1@zju.edu.cn (Yangwei Jiang)</author>
      <author>wangzhiye1@zju.edu.cn (Yanqing Yang)</author>
      <author>wangzhiye1@zju.edu.cn (Zhiye Wang)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.107785</guid>
      <category>Structural Biology and Molecular Biophysics</category>
      <pubDate>Tue, 14 Jul 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-07-14T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Lenacapavir-induced lattice hyperstabilization is central to HIV-1 capsid failure at the nuclear pore complex and in the cytoplasm</title>
      <link>https://elifesciences.org/articles/109282</link>
      <description>Lenacapavir (LEN) is the first human immunodeficiency virus type 1 (HIV-1) capsid inhibitor approved for clinical use in humans. It inhibits multiple steps of the viral life cycle; however, the molecular details of the effect of LEN on capsid structure and the mechanistic steps of the inhibition are not understood. Recent studies show that intact cone-shaped capsids and capsids with LEN-induced breaks can dock at nuclear pore complexes (NPCs), but only intact capsids enter the nucleus. In this work, we combined large-scale coarse-grained molecular dynamics simulations and live-cell imaging to investigate the stepwise mechanism of docking of LEN-treated capsids into the NPC. Capsids bound to substoichiometric concentrations of LEN can reach the NPC central channel. As the capsid advances to the nuclear end, lattice defects are formed at the pentamer-hexamer interface – primarily at the narrower end – leading to pentamer dissociation. Dissociation of pentamers is detrimental to capsid integrity, leading to both rupture of the narrow end and destabilization of the hexamer-hexamer interface. Structural analysis of LEN-capsid complexes in our simulations demonstrates heterogeneous hyperstabilization and loss of the essential pliability of the capsid protein lattice. Live-cell imaging of HIV-1 cores labeled with two different fluorescent markers showed that LEN-treated ruptured capsids were docked at the NPC but were not imported into the nucleus. We conclude that LEN contributes to the loss of capsid elasticity and integrity, inhibiting HIV-1 nuclear entry and replication. Our findings demonstrate that altering viral material properties can be an effective strategy for designing human antiviral drugs.</description>
      <author>gavoth@uchicago.edu (Arpa Hudait)</author>
      <author>gavoth@uchicago.edu (Ellie K Bare)</author>
      <author>gavoth@uchicago.edu (Gregory A Voth)</author>
      <author>gavoth@uchicago.edu (Ryan C Burdick)</author>
      <author>gavoth@uchicago.edu (Vinay K Pathak)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.109282</guid>
      <category>Structural Biology and Molecular Biophysics</category>
      <pubDate>Wed, 08 Jul 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-07-08T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Conformational variability of HIV-1 Env trimer and viral vulnerability</title>
      <link>https://elifesciences.org/articles/110107</link>
      <description>Human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (Env) is critical for viral fusion and entry into host cells and remains a primary target for vaccine and antiviral drug development. Advances in soluble gp140 trimer design have provided insight into the ectodomain structure and dynamics. While structural information is available for the membrane-proximal external region (MPER) and transmembrane domain (TMD), these regions remain comparatively understudied. Furthermore, high-resolution structural information for the cytoplasmic tail (CT), particularly within the context of the intact trimer, is limited and largely uncertain. Additionally, previous studies have typically treated the ectodomain and TMD as separate entities. To investigate the trimeric gp120–gp41 as a complete entity and its structural flexibility, we built a full-length model of the gp120–gp41 trimer that is fully glycosylated with N-linked glycans and embedded in a lipid bilayer, and performed all-atom molecular dynamics simulations. Our results show that the ectodomain maintains a rigid internal structure stable in the prefusion state, whereas the intrinsic flexibility of the MPER enables the ectodomain to adopt a range of tilted orientations, potentially enhancing spatial alignment for receptor engagement. The centrally positioned R696 residue in the TMD interacts with lipid headgroups, ions, and CT residues, resulting in conformational variability in the TMD and perturbations in the surrounding membrane that may facilitate the fusion process. Finally, we demonstrate how simulation trajectories can be leveraged to evaluate the accessibility of antibody epitopes across different regions of the protein.</description>
      <author>wonpil@lehigh.edu (Wonpil Im)</author>
      <author>wonpil@lehigh.edu (Yiwei Cao)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.110107</guid>
      <category>Structural Biology and Molecular Biophysics</category>
      <pubDate>Fri, 26 Jun 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-06-26T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Structural insights into the recruitment of viral type 2 IRES to ribosomal preinitiation complex for protein synthesis</title>
      <link>https://elifesciences.org/articles/107788</link>
      <description>Picornaviruses employ internal ribosome entry sites (IRESs) in their genomic RNA to hijack the host’s translational machinery. The picornavirus, encephalomyocarditis virus, employs a type 2 IRES present in its 5’ untranslated region (5’UTR) and requires 43S ribosomal preinitiation complex (PIC), the central domain of eukaryotic initiation factor (eIF) 4G, eIF4A, and an essential ITAF (IRES trans-acting factor)-polypyrimidine tract binding protein 1 (PTB1) to form 48S PIC. In this study, we have used cryo-electron microscopy (cryo-EM) to determine the structure of encephalomyocarditis virus (EMCV) IRES-bound mammalian 48S PIC in a scanning-arrested closed state at the start codon. The EMCV IRES domains contact initiator tRNA (tRNA&lt;sub&gt;i&lt;/sub&gt;) and 40S head at the inter-subunit interface, which reveals an altogether unique mechanism used by viruses to capture host translational machinery for its protein synthesis. The tRNA&lt;sub&gt;i&lt;/sub&gt; is held away from the 40S body in contrast to canonical cap-dependent translation while the domain I apical region of EMCV IRES mimics 28S rRNA of 60S to interact with 40S ribosomal head proteins uS13 and uS19. The structural analysis accounts for numerous previously reported biochemical studies on type 2 IRES and shows how type 2 IRES interacts with 43S PIC to form 48S PIC. This study provides mechanistic insights for understanding EMCV IRES-mediated translation initiation, which could be extrapolated to other IRESs sharing similar motifs and factor requirements, including type 1 viral IRESs.</description>
      <author>hussain@iisc.ac.in (Deepakash Das)</author>
      <author>hussain@iisc.ac.in (Tanweer Hussain)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.107788</guid>
      <category>Biochemistry and Chemical Biology</category>
      <category>Structural Biology and Molecular Biophysics</category>
      <pubDate>Thu, 25 Jun 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-06-25T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Intraflagellar transport protein IFT172 contains a C-terminal ubiquitin-binding U-box-like domain involved in ciliary signaling</title>
      <link>https://elifesciences.org/articles/104906</link>
      <description>Intraflagellar transport (IFT) is a fundamental process driving ciliogenesis in most eukaryotic organisms. IFT172, the largest protein of the IFT complex, plays a crucial role in cilium formation, and several disease-causing IFT172 variants have been identified in ciliopathy patients. While IFT172 is tethered to the IFT-B complex via its N-terminal domains, the function of its C-terminal domains has remained elusive. Here, using both human and &lt;i&gt;Chlamydomonas reinhardtii&lt;/i&gt; IFT172, we reveal that the C-terminal part of IFT172 interacts with IFT-A complex subunits, providing a molecular basis for the role of IFT172 in bridging IFT-A and IFT-B complexes. We determine the crystal structure of the C-terminal part of IFT172, uncovering a conserved U-box-like domain often found in E3 ubiquitin ligases. This domain exhibits ubiquitin-binding properties, and IFT172 undergoes ubiquitin conjugation in vitro, an activity that is reduced in the C1727R patient ciliopathy variant. We use CRISPR-engineered RPE-1 cells to demonstrate that the U-box-like domain is essential for IFT172 protein stability and proper cilium formation. Notably, RPE-1 cells with heterozygous deletion of the U-box domain show altered TGF-β signaling responses, particularly in SMAD2 phosphorylation levels and AKT activation. Our findings suggest that IFT172, beyond its structural role in bridging IFT-A and IFT-B complexes within IFT trains, harbors a conserved U-box-like domain with potential involvement in ciliary ubiquitination processes and signaling, providing new insights into the molecular mechanisms underlying IFT172-related ciliopathies.</description>
      <author>bhogaraju@embl.fr (Anna Lorentzen)</author>
      <author>bhogaraju@embl.fr (Anni Christensen)</author>
      <author>bhogaraju@embl.fr (Esben Lorentzen)</author>
      <author>bhogaraju@embl.fr (Jens S Andersen)</author>
      <author>bhogaraju@embl.fr (Jiaolong Wang)</author>
      <author>bhogaraju@embl.fr (Jindriska L Fialova)</author>
      <author>bhogaraju@embl.fr (Lucie Menguy)</author>
      <author>bhogaraju@embl.fr (Narcis A Petriman)</author>
      <author>bhogaraju@embl.fr (Nevin K Zacharia)</author>
      <author>bhogaraju@embl.fr (Niels Boegholm)</author>
      <author>bhogaraju@embl.fr (Sagar Bhogaraju)</author>
      <author>bhogaraju@embl.fr (Sophie Saunier)</author>
      <author>bhogaraju@embl.fr (Søren Tvorup Christensen)</author>
      <author>bhogaraju@embl.fr (Stefanie Kuhns)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.104906</guid>
      <category>Structural Biology and Molecular Biophysics</category>
      <pubDate>Tue, 23 Jun 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-06-23T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Characterization and modulation of human insulin degrading enzyme conformational dynamics to control enzyme activity</title>
      <link>https://elifesciences.org/articles/105761</link>
      <description>Insulin degrading enzyme (IDE) is a dimeric M16A zinc metalloprotease that degrades amyloidogenic peptides diverse in shape and sequence, including insulin and amyloid-β, to prevent toxic amyloid fibril formation. IDE has a hollow catalytic chamber formed by two ~55 kDa N- and C- domains (IDE-N and IDE-C, respectively), in which peptides bind, unfold, and are repositioned for proteolysis. IDE is known to transition between a closed state, poised for catalysis, and an open state, able to release cleavage products and bind a new substrate. Here, we present six cryo-EM structures of the IDE dimer at 3.0–5.1 Å resolution, obtained in the presence of a sub-saturating concentration of insulin. Combining cryo-EM heterogeneity analysis with all-atom molecular dynamics (MD) simulations, we identified the structural basis and key residues for IDE conformational dynamics that were not previously revealed by IDE static structures. Notably, R668 serves as a molecular latch mediating the open-close transition and facilitates key protein motions through charge-swapping interactions at the IDE-N/C interface. Our small-angle X-ray scattering analysis and enzymatic assays of an R668A mutant indicate a profound alteration of conformational dynamics and catalytic activity. By integrating coarse-grained MD simulations, our analysis reveals that IDE unfolds its substrates through the coordinated motion between IDE-N and IDE-C, as well as β-sheet formation between IDE and insulin. Additionally, our time-resolved cryo-EM analysis uncovers IDE allostery within the IDE dimer. Collectively, our findings demonstrate the strength of combining experimental and computational approaches to probe protein dynamics and pave the way for developing substrate-specific modulators of IDE activity.</description>
      <author>wtang@bsd.uchicago.edu (Bridget Carragher)</author>
      <author>wtang@bsd.uchicago.edu (Clinton S Potter)</author>
      <author>wtang@bsd.uchicago.edu (Hui Wei)</author>
      <author>wtang@bsd.uchicago.edu (Jordan M Mancl)</author>
      <author>wtang@bsd.uchicago.edu (Joshua H Mendez)</author>
      <author>wtang@bsd.uchicago.edu (Nicholas L Bayhi)</author>
      <author>wtang@bsd.uchicago.edu (Tobin R Sosnick)</author>
      <author>wtang@bsd.uchicago.edu (Wei-Jen Tang)</author>
      <author>wtang@bsd.uchicago.edu (Wenguang G Liang)</author>
      <author>wtang@bsd.uchicago.edu (William C Budell)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.105761</guid>
      <category>Structural Biology and Molecular Biophysics</category>
      <pubDate>Mon, 08 Jun 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-06-08T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Direct MRI of collagen</title>
      <link>https://elifesciences.org/articles/109799</link>
      <description>Collagen is the most abundant protein in the human body and has an important role in healthy tissue as well as in a range of prevalent diseases. Medical research and diagnostics, hence, call for means of mapping collagen in vivo. Magnetic resonance imaging (MRI) is a natural candidate for this task, offering full 3D capability and versatile contrast non-invasively. However, collagen has so far been invisible to MRI due to extremely short lifetime of its resonances. Here, we report the direct imaging of collagen in vivo by magnetic resonance on the microsecond scale. The dynamics of resonance signals from collagen were first assessed in samples of bovine tendon and cortical bone. On this basis, imaging was performed at echo times down to 10 microseconds, yielding collagen-specific depiction by echo subtraction. The same approach was then extended for use in vivo, enabling direct collagen imaging of a human forearm. This capability suggests significant promise for biomedical science and clinical use.</description>
      <author>weiger@biomed.ee.ethz.ch (Emily Louise Baadsvik)</author>
      <author>weiger@biomed.ee.ethz.ch (Jason Daniel Van Schoor)</author>
      <author>weiger@biomed.ee.ethz.ch (Klaas P Pruessmann)</author>
      <author>weiger@biomed.ee.ethz.ch (Markus Weiger)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.109799</guid>
      <category>Medicine</category>
      <category>Structural Biology and Molecular Biophysics</category>
      <pubDate>Thu, 04 Jun 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-06-04T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Dissecting mechanisms of ligand binding and conformational changes in the glutamine-binding protein</title>
      <link>https://elifesciences.org/articles/95304</link>
      <description>The glutamine-binding protein GlnBP is part of an ATP-binding cassette transporter system in &lt;i&gt;Escherichia coli&lt;/i&gt; and uses two well-characterized conformational states, an open ligand-free and a closed-liganded state, to facilitate active amino-acid uptake. Existing literature on its ligand-binding mechanism lacked sufficient evidence to univocally assign the kinetic type of binding mechanism for GlnBP: ligand binding prior to conformational change, that is an induced fit, or the conformational selection, in which the ligand binds the matching conformation from a pre-existing ensemble. Since such mechanistic questions are relevant for our fundamental understanding of how this and other biomacromolecules regulate cellular processes, we here revisit the question for GlnBP. We present a biochemical and biophysical analysis using a combination of calorimetry, single-molecule and surface-plasmon resonance spectroscopy, and molecular dynamics simulations. We found that both apo- and holo-GlnBP show no detectable exchange between open and (semi-)closed conformations on timescales between 100 ns and 10 ms and that ligand binding and conformational changes in GlnBP are correlated. A global analysis of our experimental results suggests that the conformational selection model is only compatible with GlnBP for the extreme scenario of very fast conformational exchange between the open and closed states on timescales &amp;lt;100 ns. In contrast, all data remains compatible with an induced-fit mechanism, where the ligand binds GlnBP prior to conformational rearrangements. Importantly, our work demonstrates that it is an intricate task to identify the type of kinetic binding mechanism and that this requires not only a sufficient set of data, but also an integrative experimental and theoretical framework to address the question. Based on this concept, we propose that various protein systems, for which so far only insufficient kinetic data are available, should be revisited.</description>
      <author>thomas.weikl@mpikg.mpg.de (Alessandra Narducci)</author>
      <author>thomas.weikl@mpikg.mpg.de (Anna Herr)</author>
      <author>thomas.weikl@mpikg.mpg.de (Don C Lamb)</author>
      <author>thomas.weikl@mpikg.mpg.de (Douglas Griffith)</author>
      <author>thomas.weikl@mpikg.mpg.de (Ecenaz Bilgen)</author>
      <author>thomas.weikl@mpikg.mpg.de (Eitan Lerner)</author>
      <author>thomas.weikl@mpikg.mpg.de (Kirsten Jung)</author>
      <author>thomas.weikl@mpikg.mpg.de (Marija Ram)</author>
      <author>thomas.weikl@mpikg.mpg.de (Michael Isselstein)</author>
      <author>thomas.weikl@mpikg.mpg.de (Niels Zijlstra)</author>
      <author>thomas.weikl@mpikg.mpg.de (Oliver Brix)</author>
      <author>thomas.weikl@mpikg.mpg.de (Paul David Harris)</author>
      <author>thomas.weikl@mpikg.mpg.de (Pazit Con)</author>
      <author>thomas.weikl@mpikg.mpg.de (Sabrina Panhans)</author>
      <author>thomas.weikl@mpikg.mpg.de (Sophie Brameyer)</author>
      <author>thomas.weikl@mpikg.mpg.de (Thomas R Weikl)</author>
      <author>thomas.weikl@mpikg.mpg.de (Thorben Cordes)</author>
      <author>thomas.weikl@mpikg.mpg.de (Zhongying Han)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.95304</guid>
      <category>Structural Biology and Molecular Biophysics</category>
      <pubDate>Tue, 02 Jun 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-06-02T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>A novel RAB5 binding site in human VPS34-CII that is likely the primordial site in eukaryotic evolution</title>
      <link>https://elifesciences.org/articles/110040</link>
      <description>RAB5-GTP activation of the multiprotein VPS34 complex II (VPS34-CII) is critical for endosomal sorting and maturation, phagocytosis, and receptor downregulation. RAB5-GTP activates VPS34-CII by binding to a helical insertion in the C2 domain of VPS34 on the BECLIN1/UVRAG-containing adaptor arm of the complex. The autophagy complex, VPS34 complex I (VPS34-CI), features a unique ATG14L subunit in place of the VPS34-CII UVRAG subunit, and we found that this distorts the adaptor arm to alter the VPS34 RAB-GTPase binding pocket so that it preferentially binds RAB1-GTP. Surprisingly, our higher-resolution single-particle cryo-EM structure of VPS34-CII showed a second RAB5-GTP binding site on the VPS15 solenoid region. This site (VPS15-RAB5-site) appears to be the primordial RAB5-binding region. A mutant in the helical insertion of the C2 domain of human VPS34 that mimics the &lt;i&gt;Saccharomyces cerevisiae&lt;/i&gt; sequence abolishes RAB5 binding to VPS34. Mutation of the VPS15-RAB5-site ortholog in &lt;i&gt;S. cerevisiae&lt;/i&gt; VPS15 resulted in defective CPY sorting, loss of colocalisation with the RAB5 ortholog Vps21, and loss of binding to Vps21 in vitro. Evolutionary expansion from one to two RAB5-orthologue binding sites may have increased membrane binding and VPS34-CII activity to adapt to more complex endocytic systems.</description>
      <author>rlw@mrc-lmb.cam.ac.uk (Antoine Nicolas Dessus)</author>
      <author>rlw@mrc-lmb.cam.ac.uk (Maxime Bourguet)</author>
      <author>rlw@mrc-lmb.cam.ac.uk (Roger L Williams)</author>
      <author>rlw@mrc-lmb.cam.ac.uk (Saule Spokaite)</author>
      <author>rlw@mrc-lmb.cam.ac.uk (Yohei Ohashi)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.110040</guid>
      <category>Structural Biology and Molecular Biophysics</category>
      <pubDate>Thu, 28 May 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-05-28T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Effects of residue substitutions on the cellular abundance of proteins</title>
      <link>https://elifesciences.org/articles/103721</link>
      <description>Multiplexed assays of variant effects (MAVEs) make it possible to measure the functional impact of all possible single amino acid residue substitutions in a protein in a single experiment. Combination of variant effect data from several such experiments provides the opportunity to conduct large-scale analyses of variant effect scores measured across proteins, but can be complicated by variations in the phenotypes that are probed across experiments. Thus, using variant effect datasets obtained with similar MAVE techniques can help reveal general rules governing the effects of amino acid variation for a single molecular phenotype. In this work, we accordingly combined data from six individual variant abundance by massively parallel sequencing (VAMP-seq) experiments and analysed a total of 31,614 variant effect scores reporting solely on the impact of single amino acid residue substitutions on the cellular abundance of proteins. Using our combined variant effect dataset, we derived and analysed a collection of amino acid substitution matrices describing the average impact on cellular abundance of all residue substitution types in different structural environments. We found that the substitution matrices predict the cellular abundance of protein variants with surprisingly high accuracy when given structural information only in the form of whether a residue is buried or exposed. We thus propose our substitution matrix-based predictions as strong baselines for future abundance model development.</description>
      <author>lindorff@bio.ku.dk (Kresten Lindorff-Larsen)</author>
      <author>lindorff@bio.ku.dk (Thea K Schulze)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.103721</guid>
      <category>Biochemistry and Chemical Biology</category>
      <category>Structural Biology and Molecular Biophysics</category>
      <pubDate>Thu, 28 May 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-05-28T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Twelve phosphomimetic mutations induce the assembly of recombinant full-length human tau into paired helical filaments</title>
      <link>https://elifesciences.org/articles/104778</link>
      <description>The assembly of tau into amyloid filaments is associated with more than 20 neurodegenerative diseases, collectively termed tauopathies. Electron cryo-microscopy (cryo-EM) structures of brain-derived tau filaments revealed that specific structures define different diseases, triggering a quest for the development of experimental model systems that replicate the structures of disease. Here, we describe 12 phosphomimetic serine/threonine-to-aspartate mutations in tau, which we term PAD12, that collectively induce the in vitro assembly of full-length three-repeat tau into filaments with the same structure as paired helical filaments extracted from the brains of individuals with Alzheimer’s disease. Solution-state nuclear magnetic resonance spectroscopy suggests that phosphomimetic mutations in the carboxy-terminal domain of tau may facilitate filament formation by disrupting an intramolecular interaction between two IVYK motifs. PAD12 tau can be used for both nucleation-dependent and multiple rounds of seeded assembly in vitro, as well as for the seeding of tau biosensor cells. PAD12 tau can be assembled into paired helical filaments under various shaking conditions, with the resulting filaments being stable for extended periods of time. They can be labelled with fluorophores and biotin. Tau filaments extracted from the brains of individuals with Alzheimer’s disease have been known to be made of hyperphosphorylated and abnormally phosphorylated full-length tau, but it was not known if the presence of this post-translational modification is more than a mere correlation. Our findings suggest that hyperphosphorylation of tau may be sufficient for the formation of the Alzheimer tau fold. PAD12 tau will be a useful tool for the study of molecular mechanisms of neurodegeneration.</description>
      <author>mg@mrc-lmb.cam.ac.uk (Jane L Wagstaff)</author>
      <author>mg@mrc-lmb.cam.ac.uk (Jenny Shi)</author>
      <author>mg@mrc-lmb.cam.ac.uk (Michel Goedert)</author>
      <author>mg@mrc-lmb.cam.ac.uk (Sjors HW Scheres)</author>
      <author>mg@mrc-lmb.cam.ac.uk (Sofia Lövestam)</author>
      <author>mg@mrc-lmb.cam.ac.uk (Stefan MV Freund)</author>
      <author>mg@mrc-lmb.cam.ac.uk (Taxiarchis Katsinelos)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.104778</guid>
      <category>Structural Biology and Molecular Biophysics</category>
      <pubDate>Wed, 20 May 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-05-20T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Natural xanthones as α-Mangostin induce vasorelaxation involving key gating residues in the S6 domain of BK channels</title>
      <link>https://elifesciences.org/articles/109479</link>
      <description>Polyphenolic compounds are widely explored for health benefits, including hypertension, but their active ingredients, molecular targets, and mechanisms remain poorly defined. We identify the xanthone Mangostin from &lt;i&gt;Garcinia mangostana&lt;/i&gt; as a potent modulator of several potassium channels, with large-conductance K&lt;sup&gt;+&lt;/sup&gt; (BK) channels as its primary target for vasorelaxation. Mangostin-activated BK channels as α subunits alone, in complexes with vascular β1 subunits, and in reconstituted BKα/β1–Ca&lt;sub&gt;v&lt;/sub&gt; nanodomains. It shifted BK voltage activation to more negative potentials by antagonizing channel closure and promoting channel opening without markedly altering Ca²&lt;sup&gt;+&lt;/sup&gt; sensitivity. Docking, competition, single-channel analysis, and mutagenesis localized the binding site in the pore cavity below the SF, involving gating-critical S6 residues I308, L312, and A316, and suggest that Mangostin stays bound in closed and open states. These findings establish BK channel activation as the core molecular mechanism driving Mangostin’s vascular effects and define its structural mode of action, informing nutraceutical safety assessment and BK-targeted drug design.</description>
      <author>m.musinszki@physiologie.uni-kiel.de (Marianne A Musinszki)</author>
      <author>m.musinszki@physiologie.uni-kiel.de (Robert Patejdl)</author>
      <author>m.musinszki@physiologie.uni-kiel.de (Soenke Cordeiro)</author>
      <author>m.musinszki@physiologie.uni-kiel.de (Thomas Baukrowitz)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.109479</guid>
      <category>Biochemistry and Chemical Biology</category>
      <category>Structural Biology and Molecular Biophysics</category>
      <pubDate>Wed, 06 May 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-05-06T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
  </channel>
</rss>
